Press Releases
 
Press Releases
  Date Title and Summary View
Nov 12, 2014
Exact Sciences' new colon cancer screening test recognized as a revolution in healthcare MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (NASDAQ: EXAS) today announced Cologuard has received a 2014 "Best of What's New" award from Popular Science. Colog...
Nov 6, 2014
Updated guidelines include recommended use of noninvasive stool-based DNA screening test every three years MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (NASDAQ: EXAS) today announced that the American Cancer Society's Colorectal Cancer Prevention and Early Detection ...
Nov 5, 2014
MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company will participate in three investor conferences during November. Maneesh K. Arora, the company's chief operating officer, will participate in a fireside chat at the Stephens Fall Investment ...
Oct 29, 2014
Meriter partners with Exact Sciences in effort to get more patients screened for colorectal cancer MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (NASDAQ: EXAS) today announced that Meriter-UnityPoint Health will now offer Cologuard®, the first and only FDA appr...
Oct 27, 2014
MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (Nasdaq:EXAS) today announced its financial results for the quarter ended Sept. 30, 2014. Exact reported total revenues of $0.0 million for the third quarter of 2014, compared to $1.0 million for the third quarter of 2013. Total revenu...
Oct 22, 2014
BOCA RATON, Fla. & MADISON, Wis.--(BUSINESS WIRE)-- MDVIP, the leader in personalized preventive medicine with a nationwide network of over 750 affiliated primary care physicians, announced today that Cologuard®, the first and only¬†Food and Drug Administration¬†(FDA) approved, noninvasive stool DNA ...
Oct 20, 2014
MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company will host a webcast and conference call to discuss its third-quarter 2014 financial results on Oct. 27, 2014. Third-Quarter 2014 Webcast and Conference Call Details ...
Oct 9, 2014
CMS to cover the first and only FDA-approved noninvasive stool DNA screening test for colorectal cancer MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (NASDAQ: EXAS) today announced that the Centers for Medicare & Medicaid Services (CMS) issued its final National Coverage ...
Sep 22, 2014
Stool-based DNA (sDNA) screening test for colorectal cancer to be available by prescription to patients at Group Health Cooperative Clinics MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (NASDAQ: EXAS) today announced that Group Health Cooperative will be the first health pla...
Aug 28, 2014
MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company will participate in Baird's 2014 Health Care Conference in New York. Kevin T. Conroy, the company's chairman and chief executive, will make Exact's presentation at 9:05 a.m. ET on Thursday, Sept. ...
Page:
1
... NextLast
= add release to Briefcase